MedPath
TGA Approval

APRETUDE cabotegravir (as sodium) 30 mg film coated tablet bottle (377442)

377442

APRETUDE cabotegravir (as sodium) 30 mg film coated tablet bottle

ViiV Healthcare Pty Ltd

August 11, 2022

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/f3d58affdd9ebe7e9d62933ad7053773.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/6ffb93ccc46350b53298326d00e78dd5.pdf

Active Ingredients

cabotegravir sodium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APRETUDE cabotegravir (as sodium) 30 mg film coated tablet bottle (377442) - TGA 批准文号 | MedPath